文献速递血栓与止血

ChAdOx1 nCoV-19疫苗通过剪切依赖性血小板聚集:动脉血栓形成的新型生物物理机制

Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis.
PubMed 文献 · Blood · 2025-01-01

研究探讨ChAdOx1 nCoV-19疫苗相关罕见血栓事件的机制,采用微流控血栓形成实验发现该疫苗在动脉剪切条件下经血小板整合素αIIbβ3诱导剪切依赖性血小板聚集,与常规血管性血友病因子介导的黏附不同,为疫苗相关动脉血栓事件提供了一种区别于疫苗诱导免疫性血栓性血小板减少症的新解释。

要点

  • ChAdOx1在动脉剪切条件下经整合素αIIbβ3诱导剪切依赖性血小板聚集。
  • 该结合依赖生物力学激活,静态条件下无显著结合。
  • 抑制整合素αIIbβ3完全消除聚集,阻断GP Ib影响极小。

核心结论

  • ChAdOx1经其五邻体RGD基序与活化构象的整合素αIIbβ3结合,在剪切条件下诱导血小板聚集,为疫苗接种后动脉血栓事件提供了区别于疫苗诱导免疫性血栓性血小板减少症的新型生物物理机制。

研究设计与样本

  • 采用微流控血栓形成实验、分子动力学模拟与对接研究、突变分析,研究ChAdOx1与血小板在动脉剪切条件下的相互作用。

主要发现

  • 微流控血栓形成实验显示ChAdOx1诱导剪切依赖性血小板聚集,不同于常规血管性血友病因子介导的黏附。
  • 该相互作用由血小板整合素αIIbβ3介导并需要生物力学激活,静态条件下无显著结合。
  • 分子动力学模拟与对接研究显示ChAdOx1五邻体RGD基序优先结合活化构象的αIIbβ3。
  • 抑制整合素αIIbβ3完全消除ChAdOx1诱导的血小板聚集,而阻断GP Ib影响极小。
  • 将RGD基序突变为AAA可消除血小板结合,验证了该相互作用的特异性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rare thrombotic events associated with ChAdOx1 nCoV-19 (ChAdOx1) vaccination have raised concerns; however, the underlying mechanisms remain elusive. Here, we report a novel biophysical mechanism by which ChAdOx1 directly interacts with platelets under arterial shear conditions, potentially contributing to postvaccination arterial thrombosis. Using microfluidic post assays, we demonstrate that ChAdOx1 induces shear-dependent platelet aggregation, distinct from conventional von Willebrand factor-mediated adhesion. This interaction is mediated by platelet integrin αIIbβ3 and requires biomechanical activation, explaining the absence of significant binding under static conditions. Molecular dynamics simulations and docking studies reveal preferential binding of ChAdOx1's penton arginine-glycine-aspartic acid (RGD) motif to the activated conformation of αIIbβ3. Inhibiting integrin αIIbβ3 completely abolishes ChAdOx1-induced platelet aggregation, whereas blocking glycoprotein (GP) Ib has minimal effect, confirming a mechanism that bypasses the conventional GPIb-dependent platelet adhesion pathway. Mutagenesis of the RGD motif to AAA eliminates platelet binding, verifying the specificity of this interaction. These findings provide a potential explanation for the association between ChAdOx1 vaccination and arterial thrombotic events, distinct from vaccine-induced immune thrombotic thrombocytopenia. Our results highlight the importance of considering biomechanical factors in vaccine-related thrombotic complications and suggest that shear-dependent integrin activation may be another determinant in the pathogenesis of these rare adverse events.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Chen YC, Louis NELR, Huang A, et al. Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis. Blood. 2025. PMID: 40359433. doi:10.1182/blood.2024027675

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。